Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2019

Mar 18, 2019

29871_dirs_2019-03-18_35447fff-3e0c-4323-8b4e-7065901ae715.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2019-03-14

Reporting Person: CRONIN KATHLEEN M (Sr MD Gen Counsel & Corp Secr)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-14 Common Stock Class A M 1319 $54.3 Acquired 41604 Direct
2019-03-14 Common Stock Class A S 1319 $168.0 Disposed 40285 Direct
2019-03-14 Common Stock Class A M 7021 $54.3 Acquired 47306 Direct
2019-03-14 Common Stock Class A S 7021 $167.4547 Disposed 40285 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-14 Non-Qualified Stock Option (right to buy) $54.3 M 1319 Disposed 2020-09-15 Common Stock Class A (1319) Direct
2019-03-14 Non-Qualified Stock Option (right to buy) $54.3 M 7021 Disposed 2020-09-15 Common Stock Class A (7021) Direct

Footnotes

F1: On March 14, 2019, Ms. Cronin sold a total of 7,021 shares of CME Group Class A common stock at an average price of $167.45 per share, including the exercise of options. The price ranges were $167.45 through $167.49. The Company maintains a record of the transactions and copies will be provided upon request.

F2: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option.